SCHEMBL20091019

SCHEMBL20091019

CCC(C)/C=C/c1nccnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20086553 0.81 LMNA (0.31)
SCHEMBL20091022 0.79 NFE2L2 (0.46)
SCHEMBL20091101 0.75 TYMP (0.32)
SCHEMBL20090993 0.71 LMNA (0.30)
SCHEMBL18215464 0.70
SCHEMBL23640096 0.69 RAB9A (0.54)
SCHEMBL489023 0.67 MEN1 (0.50)
SCHEMBL16874337 0.67 MEN1 (0.50)
SCHEMBL23457284 0.67
SCHEMBL20090979 0.67 NFE2L2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421751-B2 Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease LYCERA CORPORATION (US) 2019-09-24 US disclosed
US-20180111922-A1 DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATEMENT OF DISEASE LYCERA CORPORATION 2018-04-26 US disclosed